← ANALYSTS · TIPRANKS

Christopher Liu · Lucid Capital

#2941among 12,504 TipRanks analysts★★★★★★★★★★
Hits 44% 45 of 103 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +8.9% Over a year after the rating, TipRanks’ measure
Our companies rated now 4 Buy / hold / sell: 4 / 0 / 0
Upside of the analyst’s targets +279.8% Average over 4 current targets, to the last price
The market’s answer to the ratings +3.3% Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Aug 5on TipRanks 06:16 NVCTIWMNuvectis Pharma · $618M Reiterated Buy $22.00 → $34.00+54.5% +82.8% −4.0%next day −2.1% · 5 days +1.1%
Mar 2on TipRanks 06:40 RLMDIWMRelmada Therapeutics · $341M Initiated Buy $14.00 +351.6% +6.1%next day −2.6% · 5 days +49.3%
Dec 15on TipRanks 18:25 AAPGAscentage Pharma Group International Unsponsored ADR · $1.4B Initiated Buy $50.00 +225.3% +6.9%next day −2.1% · 5 days −6.9%
Oct 23on TipRanks 07:45 IPHAInnate Pharma · $176M Initiated Buy $8.00 +459.4% +4.2%next day −0.4% · 5 days −10.3%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗